Eggs and risk of cardiovascular disease: What’s the latest evidence?
Updated meta-analysis (BMJ 2020;368:m513 | doi: 10.1136/bmj.m513) show that moderate egg consumption (up to one egg per day) is not
Read more
Cardiovascular
Management of acute ischemic stroke – State of Art Review
BMJ 2020;368:l6983 Stroke is the leading cause of long term disability in developed countries and one of the top causes of
Read more
Aspirin for Primary Prevention in Diabetes Mellitus
BACKGROUND Diabetes mellitus is associated with an increased risk of cardiovascular events. Aspirin use reduces the risk of occlusive vascular
Read more
Dapagliflozin in patients with heart failure and reduced ejection fraction
BACKGROUND In patients with type 2 diabetes, inhibitors of sodium–glucose cotransporter 2 (SGLT2) reduce the risk of a first hospitalization
Read more
Statins in primary prevention – 2016
Introduction During the past few years the use of statins in primary prevention has come under scrutiny. In 2015 the
Read more
Hypertension in adults: updated NICE guidelines 2019 October
Discuss treatment with people with stage 1 hypertension and a 10 year risk for cardiovascular disease ≥10% Choice of antihypertensive drug
Read more
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Experimental and clinical evidence supports the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent
Read more